Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.
From this RSS feed
You must log in or # to comment.
Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.
From this RSS feed